Prof. Dr. Falk Nimmerjahn

Lehrstuhl für Genetik

Low level of FcγRIII expression on murine natural killer cells (2012) Biburger M, Nimmerjahn F Journal article, Original article FcγRIIB: A modulator of cell activation and humoral tolerance (2012) Lehmann B, Schwab I, Böhm S, Lux A, Biburger M, Nimmerjahn F Journal article, Review article Antibody effectors: Monocytes as mediators of immunoglobulin G-dependent effector functions (2012) Biburger M, Nimmerjahn F Journal article, Report IVIg-mediated amelioration of ITP in mice is dependent on sialic acid and SIGNR1 (2012) Schwab I, Biburger M, Krönke G, Schett G, Nimmerjahn F Journal article, Original article FcγRs in health and disease. (2011) Nimmerjahn F, Ravetch JV Journal article, Review article Fcγ receptor IIB (FcγRIIB) maintains humoral tolerance in the human immune system in vivo. (2011) Bärenwaldt A, Lux A, Danzer H, Spriewald BM, Ullrich E, Heidkamp GF, Dudziak D, Nimmerjahn F Journal article Expression and function of the inhibitory Fcγ-receptor in CIDP. (2011) Nimmerjahn F, Lünemann JD Journal article Impact of differential glycosylation on IgG activity (2011) Lux A, Nimmerjahn F Conference contribution Monocyte Subsets Responsible for Immunoglobulin G-Dependent Effector Functions In Vivo (2011) Biburger M, Aschermann S, Schwab I, Lux A, Albert H, Danzer H, Woigk M, et al. Journal article, Original article FcγRIV deletion reveals its central role for IgG2a and IgG2b activity in vivo. (2010) Nimmerjahn F, Lux A, Albert H, Woigk M, Lehmann C, Dudziak D, Smith P, Ravetch JV Journal article